Digest Network Come funziona
Digest / Comunicato

Compatibilità
Salva()
Condividi
Recapiti
Vuoi vedere nel tuo digest i prossimi comunicati di questo professionista?

Comunicati correlati

03/04/2025
Mercato azionario
Associazioni/Professionisti
Salute
Finanza
Medicina - Varie
Farmaceutica
Cardiologia
Biotecnologia
Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront
Fonte
Blackstone
Emittente
Business Wire
Scopri affinità
0
10/02/2025
Farmaceutica
Annunci Economici
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
Scopri affinità
0
02/09/2024
Salute
Medicina - Varie
Scienza
Farmaceutica
Cardiologia
Eventi
Industria
Anthos Therapeutics Unveils Additional Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating that the Factor XI Inhibitor Abelacimab was Associated with Remarkably Low Levels of Periprocedural Bleeding in Patients with Atrial Fibrillation
Fonte
Anthos Therapeutics, Inc.
Emittente
Business Wire
Scopri affinità
0